• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎病毒感染者的社会脆弱性与处方类阿片类药物使用风险增加相关。

Social vulnerability in persons with chronic hepatitis C virus infection is associated with a higher risk of prescription opioid use.

机构信息

VA Pittsburgh Healthcare System, Building 30, Mailstop 151, University Drive C, Pittsburgh, PA, 15240, USA.

Weill Cornell Medical College, New York, NY, USA.

出版信息

Sci Rep. 2021 Mar 15;11(1):5883. doi: 10.1038/s41598-021-85283-6.

DOI:10.1038/s41598-021-85283-6
PMID:33723313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961056/
Abstract

Prescription opioid use (POU) is often a precursor to opioid use disorder (OUD) and subsequent consequences. Persons with chronic hepatitis C virus infection (CHC) may be at a higher risk of POU due to a higher comorbidity burden and social vulnerability factors. We sought to determine the burden of POU and associated risk factors among persons with CHC in the context of social vulnerability. We identified CHC persons and propensity-score matched HCV- controls in the electronically retrieved Cohort of HCV-Infected Veterans and determined the frequency of acute, episodic long-term and chronic long-term POU and the prevalence of social vulnerability factors among persons with POU. We used logistic regression analysis to determine factors associated with POU. Among 160,856 CHC and 160,856 propensity-score matched HCV-controls, acute POU was recorded in 38.4% and 38.0% (P = 0.01) respectively. Episodic long-term POU was recorded in 3.9% in each group (P = 0.5), while chronic long-term POU was recorded in 28.4% and 19.2% (P < 0.0001). CHC was associated with a higher risk of chronic long-term POU (OR 1.66, 95%CI 1.63, 1.69), but not with acute or episodic long-term POU. Black race, female sex and homelessness were associated with a higher risk of chronic long-term POU. Presence of ≥ 1 factor was associated with a higher risk of all POU patterns. Persons with CHC have more social vulnerability factors and a higher risk of chronic long-term POU. Presence of ≥ 1 social vulnerability factor is associated with a higher risk of POU. Downstream consequences of POU need further study.

摘要

处方阿片类药物使用(POU)通常是阿片类药物使用障碍(OUD)和随后后果的前兆。患有慢性丙型肝炎病毒感染(CHC)的人由于合并症负担和社会脆弱性因素较高,可能面临更高的 POU 风险。我们试图确定在社会脆弱性背景下 CHC 患者中 POU 的负担和相关风险因素。我们在电子检索的 HCV 感染退伍军人队列中确定了 CHC 患者和倾向评分匹配的 HCV 对照,并确定了急性、间歇性长期和慢性长期 POU 的频率以及 POU 患者中社会脆弱性因素的患病率。我们使用逻辑回归分析来确定与 POU 相关的因素。在 160856 例 CHC 和 160856 例倾向评分匹配的 HCV 对照中,分别有 38.4%和 38.0%(P = 0.01)记录到急性 POU。两组分别有 3.9%(P = 0.5)记录到间歇性长期 POU,而慢性长期 POU 分别有 28.4%和 19.2%(P < 0.0001)记录到。CHC 与慢性长期 POU 的风险增加相关(OR 1.66,95%CI 1.63,1.69),但与急性或间歇性长期 POU 无关。黑种人、女性和无家可归与慢性长期 POU 的风险增加相关。存在≥1个因素与所有 POU 模式的风险增加相关。患有 CHC 的人有更多的社会脆弱性因素和更高的慢性长期 POU 风险。存在≥1个社会脆弱性因素与 POU 的风险增加相关。POU 的下游后果需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee0/7961056/e97af84b6de1/41598_2021_85283_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee0/7961056/e97af84b6de1/41598_2021_85283_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee0/7961056/e97af84b6de1/41598_2021_85283_Fig1_HTML.jpg

相似文献

1
Social vulnerability in persons with chronic hepatitis C virus infection is associated with a higher risk of prescription opioid use.慢性丙型肝炎病毒感染者的社会脆弱性与处方类阿片类药物使用风险增加相关。
Sci Rep. 2021 Mar 15;11(1):5883. doi: 10.1038/s41598-021-85283-6.
2
Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.美国长期接受阿片类药物治疗的人群和阿片类药物使用障碍人群的尿液药物监测趋势。
Pain Physician. 2021 Mar;24(2):E249-E256.
3
Predictors of persistent opioid use in non-cancer older adults: a retrospective cohort study.非癌症老年患者持续性阿片类药物使用的预测因素:一项回顾性队列研究。
Age Ageing. 2023 Sep 1;52(9). doi: 10.1093/ageing/afad167.
4
Prevalence and correlates of prescription opioid use among US adults, 2019-2020.2019-2020 年美国成年人处方类阿片使用的流行率和相关因素。
PLoS One. 2023 Mar 2;18(3):e0282536. doi: 10.1371/journal.pone.0282536. eCollection 2023.
5
Liver fibrosis progression in hepatitis C virus infection after seroconversion.丙型肝炎病毒感染后血清转换后的肝纤维化进展。
JAMA Intern Med. 2015 Feb;175(2):178-85. doi: 10.1001/jamainternmed.2014.6502.
6
Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.情绪调节作为共病慢性疼痛和阿片类药物使用问题的跨诊断因素。
Am Psychol. 2020 Sep;75(6):796-810. doi: 10.1037/amp0000678.
7
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).直接作用抗病毒药物治疗丙型肝炎病毒 (HCV) 可降低新发糖尿病风险:来自电子检索 HCV 感染退伍军人队列 (ERCHIVES) 的结果。
Clin Infect Dis. 2020 Mar 3;70(6):1153-1160. doi: 10.1093/cid/ciz304.
8
Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans.丙型肝炎病毒感染和未感染退伍军人的合并内科和精神疾病及药物滥用情况。
J Viral Hepat. 2007 Dec;14(12):890-6. doi: 10.1111/j.1365-2893.2007.00885.x.
9
Natural Language Processing-Identified Problem Opioid Use and Its Associated Health Care Costs.自然语言处理识别出的问题性阿片类药物使用及其相关医疗保健成本。
J Pain Palliat Care Pharmacother. 2018 Jun-Sep;32(2-3):106-115. doi: 10.1080/15360288.2018.1488794. Epub 2019 Jan 31.
10
Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting.在基层医疗环境中接受阿片类药物维持治疗的患者中,成功发现慢性丙型肝炎病例的决定因素。
Addiction. 2009 Dec;104(12):2033-8. doi: 10.1111/j.1360-0443.2009.02766.x.

引用本文的文献

1
Socioeconomic determinants of malaria and hepatitis infections: insights from the Federal Medical Center, Makurdi, North Central, Nigeria.社会经济因素对疟疾和肝炎感染的影响:来自尼日利亚中北部马库尔迪联邦医疗中心的见解。
BMC Public Health. 2024 Nov 16;24(1):3187. doi: 10.1186/s12889-024-20666-8.

本文引用的文献

1
Drug Overdose Deaths in the United States, 1999-2018.美国 1999-2018 年药物过量死亡人数。
NCHS Data Brief. 2020 Jan(356):1-8.
2
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.药物和阿片类药物相关过量死亡 - 美国,2017-2018 年。
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.
3
Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.治疗 HCV 可降低病毒相关性肝炎相关的肝相关死亡率:一项 ERCHIVES 研究。
J Hepatol. 2020 Aug;73(2):277-284. doi: 10.1016/j.jhep.2020.02.022. Epub 2020 Mar 5.
4
Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES.直接作用抗病毒药物治疗乙型和丙型肝炎合并感染患者的丙型肝炎病毒学应答:来自 ERCHIVES 的结果。
Int J Infect Dis. 2020 Mar;92:184-188. doi: 10.1016/j.ijid.2020.01.025. Epub 2020 Jan 21.
5
Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection.直接作用抗病毒药物治疗对丙型肝炎病毒感染肝外表现的影响。
Curr HIV/AIDS Rep. 2019 Oct;16(5):389-394. doi: 10.1007/s11904-019-00466-1.
6
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).直接作用抗病毒药物治疗丙型肝炎病毒 (HCV) 可降低新发糖尿病风险:来自电子检索 HCV 感染退伍军人队列 (ERCHIVES) 的结果。
Clin Infect Dis. 2020 Mar 3;70(6):1153-1160. doi: 10.1093/cid/ciz304.
7
The Opioid Epidemic in West Virginia.西弗吉尼亚州的阿片类药物流行问题。
Health Care Manag (Frederick). 2019 Apr/Jun;38(2):187-195. doi: 10.1097/HCM.0000000000000256.
8
U.S. prescribing trends of fentanyl, opioids, and other pain medications in outpatient and emergency department visits from 2006 to 2015.2006 年至 2015 年,美国在门诊和急诊就诊中外用芬太尼、阿片类药物和其他止痛药的处方趋势。
Prev Med. 2019 Jun;123:123-129. doi: 10.1016/j.ypmed.2019.03.022. Epub 2019 Mar 17.
9
Disparities Between US Opioid Overdose Deaths and Treatment Capacity: A Geospatial and Descriptive Analysis.美国阿片类药物过量死亡与治疗能力之间的差距:一项地理空间和描述性分析。
J Addict Med. 2019 Nov/Dec;13(6):476-482. doi: 10.1097/ADM.0000000000000523.
10
Assessment of Changes in the Geographical Distribution of Opioid-Related Mortality Across the United States by Opioid Type, 1999-2016.评估 1999-2016 年美国不同类阿片相关死亡率的地理分布变化及其与阿片类药物的关系。
JAMA Netw Open. 2019 Feb 1;2(2):e190040. doi: 10.1001/jamanetworkopen.2019.0040.